Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Adaptation of African Swine Virus in Non-Swine Cell Lines: A Preliminary Study for Vaccine Candidate

Jurnal Medik Veteriner · Vol. 8 No. 1 (2025) · hlm. 114–123

DOI
10.20473/jmv.vol8.iss1.2025.114-123
ISSN
2581-012X, 2615-7497
Terbit
2025-04-01
Penerbit
Universitas Airlangga
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0

Abstrak

African Swine Fever (ASF) is among the most detrimental infectious viral diseases in pigs causing approximately 100% mortality. The disease was first reported about 83 years ago in Africa before spreading to Europe in 1957 and Asia in 2010. An adequate vaccine generally containing live attenuated virus isolates prepared in swine macrophages to control the disease is currently unavailable. Therefore, this study aimed to use murine neuroblastoma (N2a) cells, non-swine cell lines, to adapt African swine fever virus (ASFV) isolates for vaccine preparation. ASFV isolate called BL21 obtained from Bali and East Nusa Tenggara was previously propagated in swine macrophages. However, virus was currently adapted in the N2a cells to avoid unwanted issues associated with using swine macrophages, including microbial contamination, as well as technically laborious and ethical issues. The adapted BL21 was re-confirmed with quantitative polymerase chain reaction (q-PCR) and tested in vivo to examine the pathogenicity properties. The results showed that BL21 produced consistently and specifically positive q-PCR, killing experimental pigs with typical gross pathological changes of ASF. BL21 at a 10-3/mL dilution adapted in N2a cells showed similar antigenic properties causing the death of nearly 50% N2a cells in vitro and terminating all in vivo experimental pigs. In conclusion, the BL21 isolate reported in this study could be used as a vaccine candidate after more attenuation and particularly to determine a lethal dose of 50% (LD50) for future investigations.

Kata kunci

Jaringan kolaborasi para penulis

28 penulis · 206 tautan kepenulisan bersama · 51 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Udayana University
  • Universitas Hindu Indonesia
  • Indonesia Open University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Romy Muhammad Dary MufaUdayana University5
I Ketut SuadaUdayana University5
I Nyoman SuarsanaUdayana University5
Made SukadaUdayana University5
I Made DwinataUdayana University5
Ida Bagus Komang ArdanaUdayana University5
Nyoman Mantik AstawaUdayana University5
Ketut Eli SupartikaAfiliasi tidak diketahui5
Ketut WirataAfiliasi tidak diketahui5
I Nyoman SuarthaUdayana University5
I Wayan Wiasthana Ika PutraIndonesia Open University1
Sofjan AripinIndonesia Open University1
Bambang SupriyonoIndonesia Open University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://e-journal.unair.ac.id/JMV/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 9 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Adaptation of African Swine Virus in Non-Swine Cell Lines: A Preliminary Study for Vaccine Candidate</dc:title>
	<dc:creator>Tenaya, I Wayan Masa</dc:creator>
	<dc:creator>Agustina, Kadek Karang </dc:creator>
	<dc:creator>Suada, I Ketut</dc:creator>
	<dc:creator>Apsari, Ida Ayu Pasti</dc:creator>
	<dc:creator>Sari, Tri Komala</dc:creator>
	<dc:creator>Handayani, Ni Made</dc:creator>
	<dc:creator>Widayantari, Anak Agung Ayu Sauca Sunia</dc:creator>
	<dc:creator>Suardana, Anak Agung Komang</dc:creator>
	<dc:creator>Sumarya, I Made</dc:creator>
	<dc:creator>Arsana, I Nyoman</dc:creator>
	<dc:creator>Sudiartawan, I Putu</dc:creator>
	<dc:creator>Wahyudi, I Wayan</dc:creator>
	<dc:creator>Juliasih, Ni Ketut Ayu</dc:creator>
	<dc:creator>Sudaryati, Ni Luh Gede</dc:creator>
	<dc:creator>Damriyasa, I Made</dc:creator>
	<dc:subject xml:lang="en-US">African swine fever</dc:subject>
	<dc:subject xml:lang="en-US">murine neuroblastoma cells</dc:subject>
	<dc:subject xml:lang="en-US">N2a cells</dc:subject>
	<dc:subject xml:lang="en-US">non-swine cell lines</dc:subject>
	<dc:subject xml:lang="en-US">pig</dc:subject>
	<dc:subject xml:lang="en-US">vaccine candidate</dc:subject>
	<dc:description xml:lang="en-US">African Swine Fever (ASF) is among the most detrimental infectious viral diseases in pigs causing approximately 100% mortality. The disease was first reported about 83 years ago in Africa before spreading to Europe in 1957 and Asia in 2010. An adequate vaccine generally containing live attenuated virus isolates prepared in swine macrophages to control the disease is currently unavailable. Therefore, this study aimed to use murine neuroblastoma (N2a) cells, non-swine cell lines, to adapt African swine fever virus (ASFV) isolates for vaccine preparation. ASFV isolate called BL21 obtained from Bali and East Nusa Tenggara was previously propagated in swine macrophages. However, virus was currently adapted in the N2a cells to avoid unwanted issues associated with using swine macrophages, including microbial contamination, as well as technically laborious and ethical issues. The adapted BL21 was re-confirmed with quantitative polymerase chain reaction (q-PCR) and tested in vivo to examine the pathogenicity properties. The results showed that BL21 produced consistently and specifically positive q-PCR, killing experimental pigs with typical gross pathological changes of ASF. BL21 at a 10-3/mL dilution adapted in N2a cells showed similar antigenic properties causing the death of nearly 50% N2a cells in vitro and terminating all in vivo experimental pigs. In conclusion, the BL21 isolate reported in this study could be used as a vaccine candidate after more attenuation and particularly to determine a lethal dose of 50% (LD50) for future investigations.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Airlangga</dc:publisher>
	<dc:date>2025-04-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://e-journal.unair.ac.id/JMV/article/view/61515</dc:identifier>
	<dc:identifier>10.20473/jmv.vol8.iss1.2025.114-123</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Medik Veteriner; Vol. 8 No. 1 (2025): April; 114-123</dc:source>
	<dc:source>2581-012X</dc:source>
	<dc:source>2615-7497</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://e-journal.unair.ac.id/JMV/article/view/61515/32229</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2025 I Wayan Masa Tenaya, Kadek Karang  Agustina, I Ketut Suada, Ida Ayu Pasti Apsari, Tri Komala Sari, Ni Made Handayani, Anak Agung Ayu Sauca Sunia Widayantari, Anak Agung Komang Suardana, I Made Sumarya, I Nyoman Arsana, I Putu Sudiartawan, I Wayan Wahyudi, Ni Ketut Ayu Juliasih, Ni Luh Gede Sudaryati, I Made Damriyasa</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc-sa/4.0</dc:rights>
</oai_dc:dc>